← FDA Drug Approvals (Drugs@FDA)

ANDA218652

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMACEUTICALS (USA) INC. · Approved 2026-09-01

Drug application

FDA Application #

ANDA218652

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

ZYDUS PHARMACEUTICALS (USA) INC.

First approval

2026-09-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown